STAT3 and ovarian cancer: HO-3867, a curcumin analog, used in combination with CDDP against CDDP-resistant human ovarian cancer (A2780R) cell line, has a synergistic efficacy with significant induction of cell cycle arrest, apoptosis, and tumor growth inhibition through STAT3 inhibition [21].